Bioactive oxylipins in type 2 diabetes mellitus patients with and without hypertriglyceridemia

Bioactive oxylipins in type 2 diabetes mellitus patients with and without hypertriglyceridemia

ObjectiveDyslipidemia, in particular elevated triglycerides (TGs) contribute to increased cardiovascular risk in type 2 diabetes mellitus (T2DM). In this pilot study we aimed to assess how increased TGs affect hepatic fat as well as polyunsaturated fatty acid (PUFA) metabolism and oxylipin formation...

Full description

Bibliographic Details
Main Authors: Yanan Xiao, Anne Pietzner, Nadine Rohwer, Adelheid Jung, Michael Rothe, Karsten H. Weylandt, Ulf Elbelt
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Endocrinology
Subjects:
oxylipins
type 2 diabetes mellitus
polyunsaturated fatty acids
controlled attenuation parameter
hypertriglyceridemia
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1195247/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1195247/full

Similar Items